Catherine Friedman has served as a member of our Board since August 2015. Ms. Friedman has been an independent financial consultant serving public and private companies in the life sciences industry since 2006. Prior to that, Ms. Friedman held numerous positions over a 23-year investment banking career with Morgan Stanley, including Managing Director from 1997 to 2006 and Head of West Coast Healthcare and Co-Head of the Biotechnology Practice from 1993 to 2006. Ms. Friedman is Chair of the Board of Grail, Inc., a life sciences company focused on early cancer detection, and a member of the boards of directors of Altaba Inc. (formerly Yahoo! Inc.) and Lyell Immunopharma, Inc., a biopharmaceutical company focused on cell-based immunotherapies for cancer. Ms. Friedman is a member of the Board of Trustees for Sacred Heart Schools in Atherton. She is a graduate of Harvard University and received an MBA from the University of Virginia’s Darden School of Business, where she is currently a Trustee. We believe Ms. Friedman is qualified to serve as a member of our Board of Directors due to her extensive experience as a member on various boards of directors, her educational background and her previous leadership and management roles.